UnitedHealthcare provides health insurance. Optum provides medical care, pharmacy services, data, technology, and business services.

Business Quality

UnitedHealth has two connected businesses.

UnitedHealthcare collects insurance premiums and pays members’ medical costs. Optum provides care, pharmacy benefits, technology, and services to patients, employers, insurers, and health care providers.

This structure gives UnitedHealth significant scale, data, provider relationships, and bargaining power across the health care system.

However, UNH is now a turnaround situation. Medical costs rose faster than expected. The company also faced management changes, regulatory investigations, restructuring, weaker Optum results, and declining membership in some areas.

The long-term business remains valuable, but investors need proof that margins and earnings can recover.

Latest Earnings

UnitedHealth reported Q1 2026 results on April 21, 2026.

Revenue: $111.7 billion, up 2%

Operating earnings: $9.0 billion, down 1%

Net income: $6.3 billion, roughly flat

Diluted EPS: $6.90

Adjusted EPS: $7.23

Operating cash flow: $8.9 billion

Medical care ratio: 83.9%, improved from 84.8%

UnitedHealthcare revenue: $86.3 billion, up 2%

UnitedHealthcare operating profit: $5.7 billion, up 9%

Optum revenue: $63.7 billion, roughly flat

Optum operating profit: $3.3 billion, down 15%

The quarter was better than expected.

UnitedHealthcare improved because of pricing changes, cost controls, and better development in prior medical claims. The medical care ratio also improved.

However, Optum remained weak. Earnings declined across several Optum businesses.

UnitedHealthcare served about 1.1 million fewer medical members than one year earlier. Medicare Advantage membership declined as the company reduced exposure to plans that were not producing acceptable returns.

Management raised its 2026 adjusted EPS outlook to more than $18.25.

Profitability & Balance Sheet

ROE: Approximately 12%

ROIC: Approximately 9%

Debt to EBITDA: Approximately 3.38x

UnitedHealth’s profitability has weakened.

ROE of 12% and ROIC of 9% are below the levels we normally prefer for a high-quality long-term compounder. The company is still profitable, but returns on capital have declined as earnings weakened and acquisitions increased the amount of capital invested in the business.

Debt to EBITDA of 3.38x is also higher than I prefer. The company still produces strong cash flow, but the balance sheet is no longer as comfortable as it was in the past.

UnitedHealth must improve earnings, strengthen Optum, and reduce leverage to rebuild its financial quality.

Moat Score

Brand Loyalty: 7

Barriers to Entry: 9

Switching Costs: 8

Network Effect: 8

Cost Advantage: 8

Final Moat Score: 8.0 / 10

Moat Rating: Wide Moat

UnitedHealth’s moat comes from its scale, insurance network, provider relationships, pharmacy operations, health care data, and regulatory experience.

However, regulation, public pressure, and government reimbursement rules can limit how much the company benefits from its scale.

Main Risks

The main risks are rising medical costs, incorrect insurance pricing, Medicare Advantage funding changes, government investigations, legal action, weaker Optum margins, cybersecurity problems, high debt, and damage to public trust.

The company must also prove that it can improve profitability without creating more pressure on patients, providers, or regulators.

For our fair value estimate, buy zones, and full investment view, join our private investing group. Members receive the complete analysis, including how we evaluate the company’s risks, current opportunity, and the price levels we consider most attractive.

Business Quality
Lululemon is still a high-quality company, but the business is going through a difficult period.
The brand has strong recognition, especially in women’s athletic apparel, yoga, and premium activewear. It also has a direct-to-consumer model, which gives the company better control over pricing, customer data, and brand experience.
The long-term opportunity is still there, especially in international markets. China and other international markets are growing much faster than North America.
However, the U.S. business is weak right now. Competition from brands like Alo, Vuori, Nike, Adidas, and many smaller athletic brands is increasing. Lululemon must improve product innovation and rebuild stronger momentum in North America.

Latest Earnings
Lululemon reported fiscal Q1 2026 results on June 4, 2026, for the quarter ended May 3, 2026.
Revenue increased 4% to $2.5 billion, or 2% on a constant-currency basis.
Americas revenue declined 3%, or 4% on a constant-currency basis. International revenue grew 22%, or 16% on a constant-currency basis.
Comparable sales increased 1%, but declined 2% on a constant-currency basis. Americas comparable sales declined 5%, while international comparable sales grew 13%.
Gross profit declined 3% to $1.3 billion. Gross margin fell to 54.2%. Operating income declined 37% to $276.9 million. Diluted EPS was $1.69, down from $2.60 last year.
The quarter was weak. Revenue still grew slightly, but margins and earnings declined sharply. The main issue is North America weakness, slower demand, higher markdowns, tariff pressure, and higher investments.
Management also lowered full-year guidance. For fiscal 2026, Lululemon now expects revenue of $11.0 billion to $11.15 billion, representing a decline of 1% to flat growth. EPS guidance is now $10.95 to $11.15.

Profitability & Balance Sheet
ROE: ~32%
ROIC: ~28%
Debt to EBITDA: 0.67
Lululemon still has a strong balance sheet. The company ended Q1 with about $1.5 billion in cash and no major traditional debt issue.
Even during a difficult period, the company remains profitable, cash-generative, and financially strong. This gives Lululemon room to invest in product innovation, stores, international growth, and buybacks.

Moat Score
Brand Loyalty: 8
Barriers to Entry: 6
Switching Costs: 5
Network Effect: 4
Cost Advantage: 6
Final Moat Score: 5.8 / 10
Moat Rating: No moat to narrow moat
Lululemon has a strong brand, but apparel is a competitive industry. Customers can switch brands easily. The moat depends heavily on brand strength, product quality, and continued customer loyalty.

For our fair value estimate, buy zones, and full investment view, join our private investing group. Members receive the complete analysis, including how we evaluate the company’s risks, current opportunity, and the price levels we consider most attractive.

Ajinomoto is a Japanese global company built around:

1. Food & Seasonings
2. Amino Acid / Bioscience Technologies
3. Electronic Materials — most notably Ajinomoto Build-up Film (ABF)

This mix creates a unique profile:
consumer-staples stability + semiconductor exposure.

What Ajinomoto Does

1️⃣ Seasonings & Foods — The Core Cash Engine

• MSG / umami seasonings
• Flavor seasonings and sauces
• Consumer packaged foods
• Strong presence in Japan and across Asia

This segment provides steady, recurring demand. These are everyday essentials, not discretionary luxuries.

2️⃣ Frozen Foods

• Domestic and overseas frozen food portfolio
• More cyclical and margin-sensitive
• Adds scale and distribution strength

3️⃣ Healthcare & Others — Where ABF Lives

This segment includes:

• Functional materials (electronic materials, including ABF)
• Bio-pharma services and ingredients
• Amino acids for pharma and food applications

This is the segment that transforms Ajinomoto from a traditional food company into a strategic materials player.

Understanding ABF (Ajinomoto Build-up Film)

ABF is a high-performance insulating film used in advanced semiconductor substrates. It enables:

• High layer counts
• Fine circuit patterning
• Strong electrical and thermal performance

It is essential for:

• CPUs
• GPUs
• AI accelerators
• High-performance servers

Without ABF-type materials, modern advanced packaging would not function at current performance levels.

Is Ajinomoto the Only Producer?

Short answer:

Not literally the only producer — but overwhelmingly dominant.

Ajinomoto (through its affiliate Ajinomoto Fine-Techno) is estimated to hold roughly 95–98% global market share in ABF film production.

That level of dominance is rare in semiconductor materials.

Some smaller alternative suppliers occasionally cited include:

• Sekisui Chemical Co., Ltd.
• WaferChem
• Taiyo Ink

However, none approach Ajinomoto’s scale or capabilities in high-density applications.

Important Distinction: ABF Film vs ABF Substrate

Many companies manufacture ABF substrates, but most rely on Ajinomoto’s film.

Major substrate makers include:

• Unimicron Technology Corp.
• Ibiden Co., Ltd.
• Nan Ya PCB Corporation
• Shinko Electric Industries Co., Ltd.
• AT&S

Ajinomoto supplies the material layer — it does not compete in substrate board manufacturing.

Business Mix: How Large Is the ABF Segment?

Ajinomoto does not break out ABF revenue separately. It sits inside:

Healthcare & Others → Functional Materials

For fiscal year ended March 31, 2025:

• Total sales: ¥1,530.5B
• Healthcare & Others sales: ¥328.3B (~21% of total)
• Total business profit: ¥159.3B
• Healthcare & Others business profit: ¥38.1B

ABF is a slice of this ~21% revenue bucket, which tends to carry higher margins than typical food operations.

Moat Analysis

Strongest Moat Area: ABF / Electronic Materials

• High customer qualification barriers
• Deep materials science know-how
• Long switching cycles
• Embedded in AI and HPC supply chains
• Extremely limited credible competition

At the business-unit level, ABF displays narrow-to-wide moat characteristics.

Moderate Moat Area: Food & Seasonings

• Strong brands and distribution
• Recurring demand
• Exposed to commodity input costs

Durable — but not a structural toll booth like Visa or ASML.

Ajinomoto as a Defensive Position

Ajinomoto functions best as a defensive-growth hybrid.

The food and seasoning businesses provide stable demand and smooth earnings during downturns. The amino acid and bio-ingredient businesses add structural healthcare exposure.

Meanwhile, ABF introduces semiconductor and AI-linked upside.

The result:

• Defensive consumer staples foundation
• Structural healthcare exposure
• Select semiconductor growth optionality

Compared to pure semiconductor equipment companies like Applied Materials, Inc. or Lam Research Corporation, Ajinomoto typically experiences lower volatility because its food business cushions industry cycles.

Defensive Score (Relative)

On a 1–10 defensive scale:

• Coca-Cola Company: 9
• Procter & Gamble: 8.5
• Ajinomoto Co., Inc.: 7–7.5

This places Ajinomoto below pure consumer staple giants, but meaningfully more defensive than most semiconductor equipment names.

Financial Snapshot

Fiscal Year Ended March 31, 2025:

• Sales: ¥1,530.5B
• Business profit: ¥159.3B

Fiscal Year Ended March 31, 2024:

• Sales: ¥1,439.2B
• Business profit: ¥147.6B
• Operating profit: ¥146.6B
• Net profit attributable to owners: ¥87.1B

Growth has been steady, supported by both staples stability and materials expansion.

Key Risks

• Semiconductor cycle volatility
• Food commodity inflation and FX exposure
• Potential long-term competition in ABF (though currently limited)

U.S. Trading Information

Ajinomoto trades primarily in Japan under:

• 2802.T (Tokyo Stock Exchange)

In the U.S., it is available via ADR:

• AJINY (OTC market)

The ADR is not listed on NYSE or Nasdaq and trades with lower liquidity compared to major exchange-listed ADRs.

Bottom Line

Ajinomoto is not a pure semiconductor powerhouse like ASML Holding N.V..

It is better described as:

Stable consumer staples cash flow + a strategically valuable semiconductor materials franchise.

For investors seeking resilience with moderate growth exposure and geographic diversification, Ajinomoto occupies a unique middle ground between traditional consumer staples and semiconductor cyclicals.

ARM Holdings plc is one of the most important technology companies in the world — even though most people have never heard of it.

ARM does not make chips.
Instead, it designs the CPU architecture that other companies use to build their chips. ARM licenses this technology to companies like Apple, NVIDIA, Qualcomm, Amazon, Samsung, and many others.

Nearly every smartphone, many laptops, and a growing number of data-center and AI systems run on ARM.

How ARM Makes Money (Why This Matters)

ARM operates a royalty and licensing model:

• Upfront license fees when customers adopt ARM designs
• Ongoing royalties every time a chip using ARM ships

ARM:

• Does not own factories
• Does not hold inventory
• Does not compete with its customers

This makes ARM a capital-light, high-margin business that can scale globally with relatively low physical risk.

Where ARM Is Used Today

ARM began in mobile, but today it spans the entire computing stack:

• Mobile: ~99% of smartphones
• PCs & laptops: Apple Silicon, Windows on ARM
• Data centers: AWS Graviton, NVIDIA Grace
• AI systems: CPUs that feed GPUs and accelerators
• Automotive & IoT: Cars, sensors, embedded devices

As power efficiency becomes more important, ARM’s relevance continues to grow.

ARM’s Moat (Why It’s Hard to Replace)

ARM’s strength is not just its technology — it’s the ecosystem:

• Decades of software built for ARM
• Compilers, operating systems, and tools already optimized
• High switching costs for customers

Once a company builds its platform around ARM, leaving is difficult and expensive. This creates a wide and durable moat.

The SoftBank Connection (Important Context)

ARM is about 90% owned by SoftBank Group.

This matters because:

• ARM is SoftBank’s crown jewel
• Buying SoftBank means buying ARM plus leverage, venture bets, and manager risk
• Buying ARM directly gives investors clean exposure to the core business

ARM is the stable engine inside SoftBank’s far more volatile structure.

Key Metrics to Know (High Level)

ARM is best judged as an IP licensing business, not a manufacturer.

Some important characteristics:

• Very high gross margins (reflecting IP economics)
• Low capital intensity (no fabs, no inventory)
• Royalty-based recurring revenue
• Low reported ROIC today, due to:
  • Heavy R&D investment
  • Accounting treatment of IP
  • Ongoing expansion into data centers and AI

Low ROIC today does not mean a weak business — it reflects front-loaded investment in a long-term moat.

Valuation: High Quality, High Expectations

ARM currently trades at a premium valuation.

The market is pricing in:

• Continued growth in AI, cloud, and custom silicon
• ARM’s expanding role beyond mobile
• Long-term operating leverage

This leaves little room for disappointment.

My Fair Value View

Based on ARM’s business quality, growth potential, and risks:

• High end of fair value: $117
• Low end of fair value: $95

How I interpret this:

• Below ~$95 → attractive
• $95–$117 → fairly valued, scale carefully
• Above ~$117 → priced for optimism

ARM is a great business, but not one to chase at any price.

Bottom Line

ARM Holdings is the quiet infrastructure layer behind modern computing — a capital-light, wide-moat licensing business that benefits as the entire tech industry grows. While SoftBank owns about 90% of ARM and uses it as the backbone of its portfolio, ARM itself offers a cleaner, lower-risk way to access this long-term thesis. The key risk today is valuation, not business quality.

When people talk about the “AI boom,” they usually imagine GPUs, data centers, and cloud computing. But behind all of that, there’s one thing every AI company desperately needs:

Electricity. A lot of it.

Data centers are growing so fast that many regions are running out of power. AI training and inference consume enormous amounts of energy, and traditional grids can’t keep up. This is where nuclear energy becomes incredibly important — and why uranium, the fuel used in nuclear reactors, is getting so much attention.

What Is Uranium and Why Is It So Useful?

Uranium is a naturally occurring metal found in the earth’s crust. It has a unique ability:

A very small amount of uranium can produce a massive amount of energy.

Here’s why it matters today:

• Nuclear power is clean — zero carbon emissions.
• It’s reliable — unlike solar and wind, it runs 24/7.
• It’s extremely energy-dense — a few pellets can power a home for months.
• It’s perfect for AI-heavy countries that need stable electricity to run data centers.

As the world enters the AI era, countries like the U.S., France, China, Japan, and South Korea are all looking to expand nuclear power. Even developing regions are planning new reactors.

This global shift brings us to a big investing question:

NUKZ vs URA — Which Nuclear ETF Should You Choose?

There are two popular ways to invest in the nuclear and uranium trend:

• NUKZ — focuses on the future of nuclear energy
• URA — focuses on uranium mining and the price of uranium

They sound similar, but they behave very differently.

Let’s break it down simply.

NUKZ: A Bet on the Future of Nuclear Energy

NUKZ invests across the entire nuclear ecosystem, including:

• Nuclear power plants and utilities
• Companies building new reactors
• Nuclear technology and engineering firms
• Fuel processing companies
• Infrastructure and services

What this means:

NUKZ does not rely purely on uranium prices. Instead, it wins when the world builds more reactors and expands nuclear power capacity.

In simple English:
NUKZ = clean energy + stable long-term nuclear growth
Broader, more diversified
Less volatile than pure uranium miners

If you believe governments and companies will build more nuclear reactors to power AI data centers, cities, and industries, NUKZ is the better choice.

URA: A Bet on a Uranium Price Boom

URA is different. It focuses mostly on uranium miners, including:

• Companies that dig uranium out of the ground
• Firms that process or enrich uranium
• A small amount of physical uranium exposure

This means URA rises and falls with uranium prices.

When uranium prices go up, miners can shoot up fast.
When prices drop, miners fall hard.

In simple English:
URA = higher risk, higher reward tied to the uranium commodity
More volatile
Best when uranium supply is tight and demand is rising

If you believe uranium prices will surge because the world doesn’t have enough supply for new reactors, URA is the better choice.

Which Is Better for You?

Here’s the simplest way to decide:

Choose NUKZ if:

• You want long-term exposure to nuclear energy
• You believe the world will build more reactors
• You prefer a smoother, more stable investment
• You want to ride the nuclear renaissance, not just uranium prices

Choose URA if:

• You want to benefit from a uranium price spike
• You’re comfortable with bigger ups and downs
• You specifically want exposure to uranium mining companies
• You want more leverage to the commodity itself

Many investors hold both

NUKZ gives long-term stability.
URA gives upside if uranium prices explode.

Together, they cover both sides of the nuclear story.

Final Thoughts

AI, electrification, and global demand for clean power are pushing the world back toward nuclear energy. Uranium sits at the center of this movement.

• If the nuclear industry grows → NUKZ benefits.
• If uranium prices rise → URA benefits.

Both ETFs play different but complementary roles.

What Chipotle Does

Chipotle is the place where you pick your own burrito, bowl, tacos, or salad and watch it get made in front of you.
They don’t franchise — meaning they own almost every restaurant themselves, so all the profit stays in-house.
Growth mainly comes from opening more stores and getting people to order through the app or drive-thru pickup lanes called Chipotlanes.

How They Make Money

Simple model: they sell food.

• About one-third of all sales come from digital orders
• Chipotlane locations make more money per store
• No franchise fees or royalty income — just restaurant revenue

Why Chipotle Stays Strong

Fast assembly-line service → more customers per hour
“Real ingredients” brand → customer loyalty + pricing power
Huge buying power → better food cost control
Chipotlanes → convenience + higher store profits

Main risks: wage inflation, food cost swings (beef, avocados), brand damage from any food-safety issue

Quick 5-Year Numbers

Key Metrics

What Can Grow the Business

1. 300+ new stores per year (mostly Chipotlanes)
2. More app + loyalty usage
3. Occasional new menu items
4. Slow but steady international expansion

Things That Could Hurt the Business

My Take

Chipotle is a rare restaurant company that funds its own growth, doesn’t need debt, and gets strong payback on every new store. But because it’s so good, the stock is usually priced high.

So I’ll only buy it if it falls to a level that makes sense long term.

My Fair Value / Buy Target: $37-39

Personal Disclaimer

I ate at Chipotle once a long time ago and didn’t enjoy the experience.
This write-up is based on the business, not the taste.

The stock market is a place where some people grow their wealth — but most people don’t. For every person who buys a stock, someone else is selling. But in the end, not everyone wins.

So… how many people actually lose money? And what do the winners do differently?

Let’s look at the facts — and what you can learn from them.

Most People Do Worse Than the Market

Everyday Investors

There’s a big research study (called DALBAR) that looked at how regular people invest. Over 30 years, here’s what they found:

• The average investor made around 6% a year
• But the overall market made about 10% a year

That may not sound like a big gap — but over time, it adds up to hundreds of thousands of dollars lost.

Why?
Because many people buy at the wrong time (when prices are high) and sell at the wrong time (when prices are low).

Most Traders Lose Money

People who trade stocks often (day traders, swing traders) do even worse.

Studies show that:

• 70% to 90% of traders lose money
• Only a few — maybe 1% to 5% — make money for years
• Most traders quit within a year because they lose too much

In one study, people who traded the most actually did the worst. They would’ve done better just buying a few good stocks and holding them.

Even the Experts Get It Wrong

What about the pros? People who manage mutual funds or hedge funds?

Most of them don’t beat the market either.

• Over the last 15 years, 9 out of 10 fund managers made less money than a basic S&P 500 index fund
• Even with fancy tools and big research teams, they still lost to the simple approach

So Who Actually Wins?

A small group of people do really well. Here’s what they usually have in common:

Fewer Stocks Can Be Better

Warren Buffett — one of the best investors ever — said it best:

“Diversification is protection against not knowing what you’re doing.”

That means: If you know your companies well, you don’t need to own 50 stocks.

Holding 10 to 20 great businesses is often much better than spreading your money across 30–40 that you don’t really believe in.

Final Thoughts: Patience Wins

The market is a place where the patient take money from the impatient.

People who lose money:

• Buy because of hype
• Sell too quickly when prices fall
• Hold bad companies too long
• Keep guessing instead of thinking

People who win:

• Buy strong companies
• Let their winners grow
• Cut losers early
• Stick to their plan

You don’t need to be perfect. You just need to be smart, patient, and focused on the long game.

One of the hardest-hit companies in this sector has been Tesla (TSLA). After reaching an all-time high in mid-December, Tesla’s stock plunged more than 55% before staging a slight rebound. This steep decline has raised concerns among investors, especially given Tesla’s historical reputation as the leader in the EV space. While broader market weakness has certainly played a role in the stock’s struggles, Tesla faces its own unique challenges as well.

Declining Sales in China and Europe

Tesla’s sales in key international markets have been declining at a concerning rate. In Europe, the company’s sales dropped 40% in February 2025 compared to the same month last year, despite an overall 26% increase in the continent’s EV market. According to the European Automobile Manufacturers’ Association, Tesla sold 16,888 vehicles in February, a sharp drop from 28,182 in February 2024, reducing its market share from 2.8% to just 1.8%. This decline can be attributed to several factors, including Elon Musk’s political affiliations, an aging product lineup, and growing competition from Chinese automakers like BYD, whose registrations in Europe surged by 94% year-over-year.

In China, the situation is even worse. Tesla’s sales plummeted by a staggering 87% in February 2025, highlighting the intensifying competition from domestic brands such as BYD, NIO, and XPeng. As Chinese automakers continue to offer competitively priced EVs with advanced features, Tesla is struggling to maintain its foothold in the world’s largest EV market.

Record-High Trade-Ins of Tesla Vehicles

Adding to Tesla’s troubles, the rate of owners trading in their Tesla vehicles has reached an all-time high. According to data from Edmunds, Tesla models from 2017 or newer accounted for 1.4% of all trade-ins until mid-March 2025, compared to just 0.4% in March of the previous year. This suggests that a growing number of Tesla owners are looking to switch brands, potentially due to concerns over the company’s brand image, leadership, or the increasing availability of compelling alternatives in the EV market.

The Elon Musk Factor

While external market forces have contributed to Tesla’s struggles, Elon Musk’s leadership has also been a point of contention. His controversial statements, political engagements, and focus on other ventures, including X (formerly Twitter) and SpaceX, have created uncertainty around Tesla’s direction. Some investors worry that Musk’s unpredictable nature and divided attention may be affecting Tesla’s ability to navigate its current challenges effectively.

The Broader EV Landscape and My Investment Stance

Despite these struggles, Tesla remains a dominant player in the EV market, boasting strong brand recognition, industry-leading battery technology, and a loyal customer base. However, as competition continues to ramp up from both legacy automakers and new EV startups, Tesla’s ability to maintain its position is far from guaranteed.

Personally, I do not invest in Tesla or the automotive industry as a whole. The sector is capital-intensive, requiring massive investments in production, infrastructure, and research and development. Additionally, competition is fierce, with both established automakers and emerging players aggressively vying for market share. The combination of high costs, unpredictable demand cycles, and razor-thin profit margins makes the auto industry a challenging investment choice for me.

As the EV landscape continues to evolve, Tesla’s future will depend on its ability to navigate these mounting challenges, innovate, and retain its competitive edge. Investors should closely monitor how the company adapts to the shifting market dynamics in the months ahead.

Are We in a Wall of Worry Right Now?

Absolutely. The market today is facing multiple concerns:

• Recession fears: Some economists warn of a potential slowdown in economic growth, though recent data remains mixed.
• Stagflation concerns: The combination of high inflation and slow growth has investors on edge, but corporate earnings have held up better than expected.
• Trade tariffs and global uncertainty: Recent geopolitical tensions and tariff policies have introduced volatility, but markets have weathered similar storms in the past.

Despite these challenges, the S&P 500 recently snapped a four-week losing streak, indicating resilience. The Volatility Index (VIX) remains elevated but not at crisis levels, suggesting that investors are cautious but not panicking. Additionally, the Fear & Greed Index is signaling a more balanced sentiment, which historically precedes bullish trends.

Examples of Past Market Rallies Despite Fear

1. 2009-2021 Bull Market: Following the 2008 financial crisis, investors were extremely cautious due to high unemployment, sluggish economic recovery, and central bank interventions. Despite these concerns, the market went on to rally for over a decade.
2. COVID-19 Recovery (2020-2021): In early 2020, fears surrounding the pandemic caused a sharp market crash. However, as businesses adapted and stimulus measures were implemented, stocks rebounded strongly, reaching new highs within months.
3. 2011 Debt Ceiling Crisis: The U.S. faced a major debt ceiling crisis, leading to fears of a government default. Despite a temporary selloff, markets quickly recovered and moved to new highs.

Why the Market Could Move Higher This Week

1. Upcoming PCE Report: The Personal Consumption Expenditures (PCE) report, which the Fed closely monitors for inflation trends, is set to be released on March 28. A softer-than-expected reading could strengthen the case for a Fed pause and drive market optimism.
2. Earnings Strength: Many companies have reported better-than-expected earnings, showing that businesses continue to generate profits despite macroeconomic challenges.
3. Federal Reserve Policy: The Fed remains cautious about cutting rates too soon, but its measured approach reassures markets.
4. Cash on the Sidelines: Many investors have been holding back due to fear, but as confidence grows, we could see significant capital flowing back into the market.
5. Technical Support Levels: Key indices, such as the S&P 500, are showing signs of support at critical technical levels, which often precede rallies.

Final Thoughts

While concerns remain, the market is showing classic signs of climbing a Wall of Worry. Historically, when skepticism is high but stocks show resilience, it often leads to a bullish breakout. This week, with earnings results rolling in and sentiment stabilizing, we may see a shift toward renewed upside momentum.

Investors should remain cautious but recognize that markets reward those who look beyond short-term fear and focus on buying great companies at a discount for long-term growth.

Step 1: Open a US Dollar Bank Account in Cambodia

To invest in US stocks, you first need a bank account that holds US dollars. Many banks in Cambodia offer this option, and it will allow you to transfer money internationally to your brokerage account.

Step 2: Build an Emergency Fund

Before investing, make sure you have an emergency fund. Aim for at least 3-6 months’ worth of living expenses in either Cambodian riel or US dollars. This ensures that if something unexpected happens, you won’t be forced to sell your investments at a bad time.

Step 3: Save Money Regularly for Investing

Start saving money in your US dollar bank account in Cambodia. It’s important to wait until you have at least $2,000-5,000 before transferring funds to your brokerage account. This reduces transfer fees as a percentage of your investment.

Step 4: Open a US Brokerage Account

To buy stocks, you need a brokerage account. At the time of this writing, the only options is Interactive Brokers (IBKR) because it allows international investors. You can apply for an account here:
Interactive Brokers Application

Step 5: Transfer Your Savings to Your Brokerage Account

Once you’ve saved at least $5,000, for example, transfer it from your Cambodian bank to your brokerage account. Be aware that this transfer costs at least $30.

• If you transfer only $1,000, the fee alone would take 3% of your capital—too high.
• If you transfer $2,000, the fee drops to 1.5%—better.
• If you transfer $5,000, the fee drops to 0.6%—much better.
• If you transfer $10,000, the fee is just 0.3%, making it even more efficient.

Step 6: Start Investing Wisely

Once your funds arrive, you can start investing. There are two main approaches:

1. Dollar-Cost Averaging (DCA) – Not Ideal for IBKR PRO

DCA means investing a fixed amount at regular intervals, such as $5 every month, no matter the stock price. However, IBKR PRO charges $1 per trade, making small purchases inefficient:

• $5 investment → $1 fee (20%) → Very expensive
• $100 investment → $1 fee (1%) → Still costly
• $1,000 investment → $1 fee (0.1%) → Much better

2. Strategic Buying – The Best Approach

A better strategy is to wait for a good price and buy in larger amounts, according to your diversification plan. This reduces trading fees and allows you to buy when stocks are undervalued.

Who Has the Advantage? Cambodia vs. the US

Many investors wonder whether people in Cambodia or the US have the advantage when it comes to investing in US stocks. Here’s a direct comparison:

Factor	Cambodia (No Capital Gains Tax)	US (With Tax)
Capital Gains Tax	0%	15%-37%
Dividend Tax	30% (US withholding tax)	15%-37%
Transfer Fees	1% or less (if optimized)	0% (direct deposit)
Trading Fees	$1 per trade (IBKR PRO fixed fee)	$0 (many brokers offer free trading)
Net Gains	Higher if fees are minimized	Lower due to taxes

Conclusion: Cambodia Wins for Capital Gains, But Not for Dividends

Even though US investors don’t pay transfer fees or trading fees, they lose a large percentage of their profits to taxes.

Cambodian investors can keep 100% of their capital gains if they minimize fees by transferring at least $5,000 at a time and investing in chunks of $1,000 or more.
However, Cambodian investors must pay a 30% dividend tax, making dividend investing less attractive. It is better to focus on growth stocks rather than dividend stocks to maximize returns.

By following this guide, investors in Cambodia can build wealth efficiently while keeping costs low. Start planning today and take full advantage of your tax-free investment environment!

Disclaimer: We are not tax attorneys, and this guide does not constitute legal or tax advice. Tax laws may change, and individual situations vary. Please consult a professional tax advisor for personalized guidance.